Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael McCall

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Surgery|May 21, 2011
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in miceMichael McCall, Christian Toso, Juliet Emamaullee, et al.
Cell Transplantation|November 9, 2010
Detecting rejection after mouse Islet transplantation utilizing islet protein-stimulated ELISPOTChristian Toso, Rena Pawlick, Stéphanie Lacotte, et al.
Dementia (London, England)|September 11, 2015
Wicking teaching aged care facilities program: Innovative PracticeAndrew Robinson, Catherine See, Emma Lea, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 8, 2023
A prospective Canadian gastroesophageal cancer database: What have we learned?Kieran Purich, Daniel Skubleny, Sunita Ghosh, et al.
Annals of Surgical Oncology|April 5, 2026
Uncovering Global Trends in Surgical Oncology Trials: Applying Natural Language Processing to ClinicalTrials.govHasnaien Ahmed, Zofia Czarnecka, Sukhdeep Jatana, et al.
Islets|September 22, 2011
AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient miceShaheed Merani, Michael McCall, Rena L Pawlick, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 14, 2009
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in cultureChristian Toso, Michael McCall, Juliet Emamaullee, et al.
Circulation|July 5, 2017
Left Ventricular Assist Device Malfunctions: It Is More Than Just the PumpRobert L Kormos, Michael McCall, Andrew Althouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric AdenocarcinomaDaniel Skubleny, Kieran Purich, David R McLean, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|September 28, 2020
Evaluation of a Health Care Performance Improvement Initiative to Facilitate Optimal Clinical Outcomes in Patients Receiving Ventricular Assist Device SupportKathleen L Lockard, Elizabeth Dunn, Nicole Kunz, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Surgery|May 21, 2011
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in miceMichael McCall, Christian Toso, Juliet Emamaullee, et al.
Cell Transplantation|November 9, 2010
Detecting rejection after mouse Islet transplantation utilizing islet protein-stimulated ELISPOTChristian Toso, Rena Pawlick, Stéphanie Lacotte, et al.
Dementia (London, England)|September 11, 2015
Wicking teaching aged care facilities program: Innovative PracticeAndrew Robinson, Catherine See, Emma Lea, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 8, 2023
A prospective Canadian gastroesophageal cancer database: What have we learned?Kieran Purich, Daniel Skubleny, Sunita Ghosh, et al.
Annals of Surgical Oncology|April 5, 2026
Uncovering Global Trends in Surgical Oncology Trials: Applying Natural Language Processing to ClinicalTrials.govHasnaien Ahmed, Zofia Czarnecka, Sukhdeep Jatana, et al.
Islets|September 22, 2011
AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient miceShaheed Merani, Michael McCall, Rena L Pawlick, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 14, 2009
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in cultureChristian Toso, Michael McCall, Juliet Emamaullee, et al.
Circulation|July 5, 2017
Left Ventricular Assist Device Malfunctions: It Is More Than Just the PumpRobert L Kormos, Michael McCall, Andrew Althouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric AdenocarcinomaDaniel Skubleny, Kieran Purich, David R McLean, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|September 28, 2020
Evaluation of a Health Care Performance Improvement Initiative to Facilitate Optimal Clinical Outcomes in Patients Receiving Ventricular Assist Device SupportKathleen L Lockard, Elizabeth Dunn, Nicole Kunz, et al.
Pageof 4